Ovid Therapeutics Inc. Quarterly Depreciation in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ovid Therapeutics Inc. quarterly/annual Depreciation history and growth rate from Q1 2016 to Q3 2024.
  • Ovid Therapeutics Inc. Depreciation for the quarter ending September 30, 2024 was $105K, a 0.96% increase year-over-year.
  • Ovid Therapeutics Inc. Depreciation for the twelve months ending September 30, 2024 was $412K, a 8.27% decline year-over-year.
  • Ovid Therapeutics Inc. annual Depreciation for 2023 was $420K, a 31.4% increase from 2022.
  • Ovid Therapeutics Inc. annual Depreciation for 2022 was $319K, a 315% increase from 2021.
  • Ovid Therapeutics Inc. annual Depreciation for 2021 was $76.9K, a 28.1% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $412K $105K +$1K +0.96% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $411K $103K -$2K -1.91% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $413K $101K -$7K -6.48% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $420K $103K -$29.1K -22.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $449K $104K +$1.93K +1.89% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $447K $105K +$50.4K +92.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $396K $108K +$77.2K +250% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $319K $132K +$108K +459% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $211K $102K +$85.6K +519% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $126K $54.6K +$36.8K +206% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $88.7K $30.8K +$11.8K +62.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $76.9K $23.5K +$5.54K +30.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 $71.3K $16.5K +$1.5K +9.98% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $69.8K $17.8K +$2.83K +18.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $67K $19K +$7K +58.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $60K $18K +$8K +80% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $52K $15K +$5K +50% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $47K $15K +$6K +66.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $41K $12K +$2K +20% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $39K $10K $0 0% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 $39K $10K +$3K +42.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $36K $9K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $36K $10K +$1K +11.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $35K $10K +$2.24K +28.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 $32.8K $7K -$171 -2.39% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $32.9K $9K +$2.35K +35.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $30.6K $9K +$3.67K +68.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $26.9K $7.76K +$2.9K +59.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $24K $7.17K +$2.8K +64% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $21.2K $6.66K +$2.66K +66.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $18.6K $5.33K +$2.27K +74.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $16.3K $4.86K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 $4.37K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $3.99K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $3.06K Jan 1, 2016 Mar 31, 2016 10-Q 2017-06-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.